The Dominican Republic maintains, within its treatment scheme against Covid-19, high-cost antiviral drugs such as Remdesivir and others with monoclonal antibodies such as Regen-CoV and Tocilizumab that are applied to positive patients who register conditions that make them vulnerable to presenting complications or seriousness.
These positive patients who have received from the first of December last to the Monoclonal antibody drugs to treat the virus must wait 90 days to apply the vaccine against Covid-19, according to the new provisions issued this Sunday by the Ministry of Salud Public.
Patients treated with antivirals and other routinely used medications to combat the virus can be vaccinated from the first month after having overcome the virus.
The two most widely used monoclonal antibody drugs in the country are Tocilizumab, introduced to the treatment scheme in 2020, it is a biological that inhibits the effect of a cytokine, interleukin-6 (IL-6), involved in inflammatory processes and the immune system.
Thus; such as Regeneron or Regen-Cov2, introduced to the country's high-cost treatment scheme in September 2021, which is a cocktail made up of two monoclonal antibodies, almost rivimab and imdevimab, and it acts as a rehabilitation drug and prevents the patient from reaching serious condition.
The Dominican Republic was the first Latin American country to introduce it to the regimen and it is frequently used as outpatient treatment.